Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Esperanza, situated in Chicago, IL, delivers tailored outpatient care for adults and children dealing with substance use disorders and simultaneous mental health conditions. The center offers outpatient services including methadone, buprenorphine, and naltrexone treatments, employing methods such as cognitive behavioral therapy and contingency management. By prioritizing personalized care, Esperanza accommodates individuals of all genders across different age groups. The program highlights brief interventions and motivational incentives, ensuring a holistic and impactful treatment journey. For those in search of effective addiction support in a nurturing setting, Esperanza is committed to assisting individuals in attaining enduring recovery.
Esperanza, situated in Chicago, IL, delivers extensive outpatient services for individuals dealing with substance abuse as well as co-occurring mental health issues, catering to both adults and children. This center offers various treatment options, including outpatient methadone/buprenorphine or naltrexone programs, standard outpatient services, and customized plans that meet the specific requirements of clients. By employing research-backed methods such as cognitive behavioral therapy and contingency management, Esperanza maintains high standards of care for both male and female adults as well as young adults. The facility prioritizes brief interventions and tailored treatment strategies, distinguishing itself through its dedication to fulfilling the distinct needs of every individual on their path to recovery.
Ethan Crossing Recovery Center, situated in Springfield, OH, delivers a thorough suite of addiction recovery solutions. They offer detox and substance abuse treatment via intensive outpatient, extended residential, and outpatient options. Emphasizing 12-step facilitation, anger management, and brief intervention, the center serves adult men and women, encompassing young adults. Ethan Crossing Recovery Center prioritizes customized support for every client, addressing their unique requirements and desires. Featuring tailored programs for various age demographics and genders, this institution is dedicated to providing superior, individualized rehabilitation to foster enduring sobriety.
Ethan Health, situated in Burlington, KY, delivers an extensive array of rehabilitation services designed for both adults and young adults dealing with substance use challenges and related mental health conditions. The center features intensive outpatient programs, outpatient detox, and various outpatient services grounded in evidence-based methodologies, including 12-step facilitation, cognitive behavioral therapy, and brief interventions. With specific programs aimed at adult men, adult women, and active duty military personnel, Ethan Health is dedicated to providing customized care tailored to the distinct needs of each client. Their focus on high-quality treatment and individualized support positions this facility as a premier choice for effective addiction recovery solutions.
Ethan Health, situated in Richmond, KY, provides a wide array of substance abuse treatment options for adults. This center addresses both co-occurring substance use disorders and severe mental health conditions in adults, as well as significant emotional issues in children. The available services include intensive outpatient care, long-term residential treatment, and standard outpatient programs. By employing research-backed strategies such as brief interventions, cognitive behavioral therapy, and the Matrix Model, Ethan Health features distinct programs tailored for adult men, women, and individuals who have faced intimate partner or domestic violence. With a commitment to personalized care, the facility serves both male and female adults, guaranteeing effective and high-quality rehabilitation support.
Euphoria Enterprises Inc, situated in Waynesville, NC, offers a wide range of outpatient detox and treatment services for both adults and young adults dealing with substance use issues. The center focuses on motivational interviewing, relapse prevention strategies, and counseling for substance use disorders. With special programs designed for pregnant or postpartum women, Euphoria provides an inclusive and nurturing atmosphere for individuals of all genders. Notable for its personalized approach and proficiency in outpatient treatments with methadone, buprenorphine, or naltrexone, this facility is committed to assisting individuals on their journey to sustainable recovery in a caring environment.
Situated in Evanston, IL, Evanston Hospital provides extensive addiction recovery services for both adults and young adults. This facility offers detoxification and treatment for substance use through various programs, including intensive outpatient, outpatient, and day treatment options. Emphasizing brief interventions, cognitive behavioral therapy, and motivational interviewing, it customizes its treatment plans to meet the unique needs of each client. With a focus on gender-specific care for both men and women, Evanston Hospital supports individuals on their recovery journey. If you are in search of personalized and evidence-driven addiction treatment, this center's dedication to high-quality care makes it an excellent option for those aiming for sustained sobriety.
Evas Village, located in Paterson, NJ, delivers thorough addiction recovery services and tailored support for individuals facing dual diagnoses of substance use disorders and significant mental health challenges, as well as emotional difficulties in young people. The facility features intensive outpatient, outpatient, and standard outpatient programs, employing therapeutic methods like anger management, motivational interviewing, and cognitive behavioral therapy. Evas Village offers specialized programs for active military personnel, adult men, and adult women, accommodating a wide range of patient needs. Open to adults and young adults of all genders, the center is committed to providing exceptional care and encouragement for those pursuing successful recovery within a supportive and understanding setting.
Evas Village, situated in Paterson, NJ, delivers complete addiction recovery services and supportive housing for adults and adolescents. This establishment focuses on addressing dual diagnoses, specifically substance use disorders alongside significant mental health conditions. Clients benefit from extended residential stays featuring continuous supervision and employ proven therapeutic methods like cognitive behavioral therapy and anger management techniques. Evas Village serves adult males and those affected by domestic violence, intimate partner abuse, or sexual trauma. Committed to exceptional care and tailored interventions, Evas Village empowers individuals pursuing lasting sobriety.
Esperanza, situated in Chicago, IL, delivers an extensive range of outpatient services for individuals dealing with substance abuse and concurrent severe mental health issues in adults, as well as significant emotional challenges in children. This center offers outpatient therapy that includes methadone/buprenorphine and naltrexone treatments, alongside general outpatient support. The programs implemented are grounded in research-backed methods, featuring brief interventions, cognitive behavioral therapy, and motivational incentives/contingency management. What sets Esperanza apart is its tailored approach, serving individuals of all genders across different age groups. Committed to delivering high-quality care, this center serves as a crucial resource for those in pursuit of effective and customized addiction recovery solutions.
Eva Mae Recovery Hope Inc, situated in Chicago, Illinois, delivers a full spectrum of addiction recovery programs for adults and adolescents. Their services encompass intensive outpatient care, general outpatient support, and medication-assisted treatment options including methadone, buprenorphine, or naltrexone. The facility employs evidence-based strategies such as 12-step program integration, anger management techniques, and brief intervention models. Eva Mae Recovery Hope Inc is dedicated to providing exceptional care and encouragement to individuals committed to their recovery path, offering tailored programs for both male and female participants. For those in search of individualized and impactful addiction treatment, this center offers a supportive and conducive setting for embarking on the road to lasting sobriety.
Outpatient detox, partial hospitalization, and intensive outpatient treatment are available at this El Paso, Texas facility, which uses buprenorphine and naltrexone for opioid and alcohol use disorders. It treats co-occurring conditions in adults and children and serves veterans and pregnant women. Medicare, Medicaid, and Spanish-language services are offered.
Rubicon Recovery Center in Watchung, New Jersey provides outpatient substance use treatment at several intensities, including partial hospitalization and intensive outpatient care, with buprenorphine and naltrexone available. Programs serve veterans, military families, pregnant and postpartum women, and criminal justice clients. TRICARE, private insurance, and self-payment accepted.
Partial hospitalization, intensive outpatient, and regular outpatient substance use treatment in Atlanta, Georgia, for clients with co-occurring mental and substance use disorders. Etowah Recovery Center uses buprenorphine and naltrexone and accepts private health insurance and cash or self-payment from young adults, adults, and seniors.
Outpatient detoxification and medication treatment with buprenorphine or naltrexone are provided in Eugene, Oregon by Eugene Health Care Center, which also treats co-occurring serious mental illness in adults. Programs serve veterans and trauma survivors. Federal funding, TRICARE, private insurance, and self-payment are accepted.
Situated in Chicago, IL, Eva Mae Recovery Hope Inc specializes in programs aimed at addressing substance use disorders. The facility offers a range of treatment options, including intensive outpatient care, standard outpatient services, and outpatient treatments featuring methadone, buprenorphine, or naltrexone. Emphasizing methods such as 12-step facilitation, anger management, and brief intervention, this center serves both adult men and women, as well as young adults. Gender-specific programs provide personalized support, ensuring that each individual receives appropriate care. Eva Mae Recovery Hope Inc is recognized for its dedication to delivering high-quality treatment and a wide array of services, making it a preferred choice for adults in need of effective addiction recovery support.
Adults in South Portland, Maine, can access outpatient detoxification and buprenorphine treatment at Everest Recovery Center. Medicare, Medicaid, SAMHSA block grants, and self-payment are accepted, making it an option for publicly insured clients seeking medication-based outpatient care.
Situated in Erie, PA, the Esper Treatment Center specializes in outpatient programs for individuals recovering from substance use disorders. The facility offers various treatment options, such as outpatient services for methadone/buprenorphine or naltrexone, traditional outpatient care, and methods like 12-step facilitation, brief interventions, and cognitive behavioral therapy. The center is equipped to serve both adult men and women, including those who have faced intimate partner violence or domestic abuse, thereby addressing a wide array of needs. Committed to delivering high-quality care, the Esper Treatment Center focuses on tailored support for all adults and young adults seeking to achieve sobriety.
Esper Treatment Center, situated in Corry, PA, delivers focused outpatient services for individuals grappling with substance use disorders. The program encompasses various modalities such as medication-assisted treatment (methadone, buprenorphine, naltrexone), standard outpatient care, and evidence-based therapies like 12-step facilitation, brief intervention, and cognitive behavioral therapy. This center is equipped to assist adult men and women, including those who have experienced intimate partner or domestic violence. Esper Treatment Center is dedicated to providing personalized and effective recovery support for all individuals.
Essential Touchstones, situated in Ridgeland, MS, delivers extensive outpatient services for addiction recovery, designed to address individual client requirements. The center provides varying levels of care, including intensive outpatient, standard outpatient, and general outpatient programs for adults, younger individuals, and older adults facing addiction and mental health challenges. Employing proven methods like cognitive behavioral therapy and anger management, the facility also features unique programs for those dealing with chronic pain and addiction simultaneously. Essential Touchstones is dedicated to providing high-quality support, with customized treatment plans for men, women, and teens on their path to healing.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.